PHARMA REVOLTA, s. r. o.
Rybné námestie 1
811 02 Bratislava – mestská časť Staré Mesto
Slovak Republic
Email: info@pharev.com
Email: pharmacovigilance@pharev.com
Med Info: 00420 737 216 920
QPPV 24/7: 00421 949 775 516
Already in the first quarter of this year, three European industry associations (EFPIA, Medicines for Europe and AESGP) published a “Call for a Mutual Recognition Agreement on Good Manufacturing Practice
After a four-year investigation by the U.K. Medicines and Healthcare Products Regulatory Agency (MHRA) (and with the support of the London Regional Asset Recovery Team, RART), the owner of Guernsey-based
The European Commission, the European Medicines Agency (EMA) and the Heads of Medicines Agencies (HMA) have updated their questions and answers document on regulatory expectations for medicinal products for human use during the
PHARMA REVOLTA, s. r. o., Rybné námestie 1, 811 02 Bratislava – mestská časť Staré Mesto, Slovak Republic
Email: info@pharev.com
Copyright: © pharma revolta 2020 ¦ nuovo.agency